THE WORLD’S FIRST
HYBRID CLOSED LOOP SYSTEM.
MINIMED® 670G SYSTEM.


The first and only system that constantly self-adjusts to automatically keep your sugar levels in range, based on how you live your everyday life.


Indicated for type 1 patients, 14 and over. Prescription required. WARNING: may not be safe for use in children under 7 or in those requiring less than 8 units of insulin per day.
 

MiniMed 670G System Highlights.

 

The MiniMed 670G system with SmartGuard® HCL technology offers two new levels of personalization:

NEW! The Suspend before low§ option avoids lows and rebound highs proactively by automatically stopping insulin 30 minutes before you reach your pre-selected low limits, then automatically restarts insulin when your levels recover, all without bothersome alerts.

NEW! The Auto Mode option automatically adjusts your basal insulin delivery every 5 minutes based on your sugar levels to keep you in target range, all day and night.

NEW! Guardian® Sensor 3 continuous glucose monitoring sensor. Introducing the most accurate sensor from Medtronic, now with up to 7 day wear and easy insertion. It is the FIRST and ONLY continuous glucose monitoring sensor FDA approved and trusted to control insulin dosing.

Exclusive CONTOUR®NEXT LINK 2.4 meter1 Get easy and accurate CGM calibration, insulin dosing and remote bolusing with our exclusive meter.

The MiniMed® 670G System?

“A life-changing breakthrough.”

“This device will mean peace of mind, in knowing a person will be in normal blood sugar range a great majority of the time,”

“Automated insulin delivery system will ease some of the burden of living with the condition”

One of "the 25 best inventions of 2016”

“We applaud the @US_FDA's approval of the first hybrid insulin delivery system.”

“It’s a medical device with the potential to change the lives of more than 1 million Americans who suffer from Type 1 diabetes.”

“A groundbreaking new device could change the lives of millions of people living with diabetes.”